Greenwich LifeSciences Inc (GLSI)
12.99
-0.20
(-1.52%)
USD |
NASDAQ |
May 29, 16:00
12.99
0.00 (0.00%)
After-Hours: 20:00
Greenwich LifeSciences Shareholders Equity (Quarterly): 5.121M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.121M |
| December 31, 2023 | 6.700M |
| September 30, 2023 | 8.853M |
| June 30, 2023 | 10.65M |
| March 31, 2023 | 11.68M |
| December 31, 2022 | 13.21M |
| September 30, 2022 | 15.41M |
| June 30, 2022 | 16.97M |
| March 31, 2022 | 19.51M |
| Date | Value |
|---|---|
| December 31, 2021 | 26.83M |
| September 30, 2021 | 28.46M |
| June 30, 2021 | 29.16M |
| March 31, 2021 | 29.75M |
| December 31, 2020 | 27.63M |
| September 30, 2020 | 4.658M |
| June 30, 2020 | -1.458M |
| December 31, 2019 | -1.350M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.458M
Minimum
Jun 2020
29.75M
Maximum
Mar 2021
14.81M
Average
13.21M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 12.81B |
| Outlook Therapeutics Inc | -134.24M |
| Gain Therapeutics Inc | 8.642M |
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.510M |
| Total Liabilities (Quarterly) | 0.3896M |